So they've published a paper on the «medium»
level security risk to maybe speed up the response time.
Not exact matches
With the potential
risk in mind, Misek and Squire, who joined the company as co-founder and CTO, created multiple
levels of
security to keep hackers out.
Actual results and the timing of events could differ materially from those anticipated in the forward - looking statements due to these
risks and uncertainties as well as other factors, which include, without limitation: the uncertain timing of, and
risks relating to, the executive search process;
risks related to the potential failure of eptinezumab to demonstrate safety and efficacy in clinical testing; Alder's ability to conduct clinical trials and studies of eptinezumab sufficient to achieve a positive completion; the availability of data at the expected times; the clinical, therapeutic and commercial value of eptinezumab;
risks and uncertainties related to regulatory application, review and approval processes and Alder's compliance with applicable legal and regulatory requirements;
risks and uncertainties relating to the manufacture of eptinezumab; Alder's ability to obtain and protect intellectual property rights, and operate without infringing on the intellectual property rights of others; the uncertain timing and
level of expenses associated with Alder's development and commercialization activities; the sufficiency of Alder's capital and other resources; market competition; changes in economic and business conditions; and other factors discussed under the caption «
Risk Factors» in Alder's Annual Report on Form 10 - K for the fiscal year ended December 31, 2017, which was filed with the
Securities and Exchange Commission (SEC) on February 26, 2018, and is available on the SEC's website at www.sec.gov.
Actual results, including with respect to our targets and prospects, could differ materially due to a number of factors, including the
risk that we may not obtain sufficient orders to achieve our targeted revenues; price competition in key markets; the
risk that we or our channel partners are not able to develop and expand customer bases and accurately anticipate demand from end customers, which can result in increased inventory and reduced orders as we experience wide fluctuations in supply and demand; the
risk that our commercial Lighting Products results will continue to suffer if new issues arise regarding issues related to product quality for this business; the
risk that we may experience production difficulties that preclude us from shipping sufficient quantities to meet customer orders or that result in higher production costs and lower margins; our ability to lower costs; the
risk that our results will suffer if we are unable to balance fluctuations in customer demand and capacity, including bringing on additional capacity on a timely basis to meet customer demand; the
risk that longer manufacturing lead times may cause customers to fulfill their orders with a competitor's products instead; the
risk that the economic and political uncertainty caused by the proposed tariffs by the United States on Chinese goods, and any corresponding Chinese tariffs in response, may negatively impact demand for our products; product mix;
risks associated with the ramp - up of production of our new products, and our entry into new business channels different from those in which we have historically operated; the
risk that customers do not maintain their favorable perception of our brand and products, resulting in lower demand for our products; the
risk that our products fail to perform or fail to meet customer requirements or expectations, resulting in significant additional costs, including costs associated with warranty returns or the potential recall of our products; ongoing uncertainty in global economic conditions, infrastructure development or customer demand that could negatively affect product demand, collectability of receivables and other related matters as consumers and businesses may defer purchases or payments, or default on payments;
risks resulting from the concentration of our business among few customers, including the
risk that customers may reduce or cancel orders or fail to honor purchase commitments; the
risk that we are not able to enter into acceptable contractual arrangements with the significant customers of the acquired Infineon RF Power business or otherwise not fully realize anticipated benefits of the transaction; the
risk that retail customers may alter promotional pricing, increase promotion of a competitor's products over our products or reduce their inventory
levels, all of which could negatively affect product demand; the
risk that our investments may experience periods of significant stock price volatility causing us to recognize fair value losses on our investment; the
risk posed by managing an increasingly complex supply chain that has the ability to supply a sufficient quantity of raw materials, subsystems and finished products with the required specifications and quality; the
risk we may be required to record a significant charge to earnings if our goodwill or amortizable assets become impaired;
risks relating to confidential information theft or misuse, including through cyber-attacks or cyber intrusion; our ability to complete development and commercialization of products under development, such as our pipeline of Wolfspeed products, improved LED chips, LED components, and LED lighting products
risks related to our multi-year warranty periods for LED lighting products;
risks associated with acquisitions, divestitures, joint ventures or investments generally; the rapid development of new technology and competing products that may impair demand or render our products obsolete; the potential lack of customer acceptance for our products;
risks associated with ongoing litigation; and other factors discussed in our filings with the
Securities and Exchange Commission (SEC), including our report on Form 10 - K for the fiscal year ended June 25, 2017, and subsequent reports filed with the SEC.
These
risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the
risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the
levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the
risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other
risks identified from time to time in Gilead's reports filed with the U.S.
Securities and Exchange Commission (the SEC).
Only third - party
security professionals can offer a neutral, objective assessment of your
level of
risk and what's at stake, writes Lapidus.
Factors that could cause or contribute to actual results differing from our forward - looking statements include
risks relating to: failure of DBRS to rate the Notes at the anticipated ratings
levels, which is a closing condition, or at all; changes in the financial markets, including changes in credit markets, interest rates, securitization markets generally and our proposed securitization in particular; the willingness of investors to buy the Notes; adverse developments regarding OnDeck, its business or the online or broader marketplace lending industry generally, any of which could impact what credit ratings, if any, are issued with respect to the Notes; the extended settlement cycle for the scheduled closing on April 17, 2018, which may exacerbate the foregoing
risks; and other
risks, including those described in our Annual Report on Form 10 - K for the year ended December 31, 2017 and in other documents that we file with the
Securities and Exchange Commission from time to time which are or will be available on the Commission's website at www.sec.gov.
Such
risks and uncertainties include, but are not limited to: our ability to achieve our financial, strategic and operational plans or initiatives; our ability to predict and manage medical costs and price effectively and develop and maintain good relationships with physicians, hospitals and other health care providers; the impact of modifications to our operations and processes; our ability to identify potential strategic acquisitions or transactions and realize the expected benefits of such transactions, including with respect to the Merger; the substantial
level of government regulation over our business and the potential effects of new laws or regulations or changes in existing laws or regulations; the outcome of litigation, regulatory audits, investigations, actions and / or guaranty fund assessments; uncertainties surrounding participation in government - sponsored programs such as Medicare; the effectiveness and
security of our information technology and other business systems; unfavorable industry, economic or political conditions, including foreign currency movements; acts of war, terrorism, natural disasters or pandemics; our ability to obtain shareholder or regulatory approvals required for the Merger or the requirement to accept conditions that could reduce the anticipated benefits of the Merger as a condition to obtaining regulatory approvals; a longer time than anticipated to consummate the proposed Merger; problems regarding the successful integration of the businesses of Express Scripts and Cigna; unexpected costs regarding the proposed Merger; diversion of management's attention from ongoing business operations and opportunities during the pendency of the Merger; potential litigation associated with the proposed Merger; the ability to retain key personnel; the availability of financing, including relating to the proposed Merger; effects on the businesses as a result of uncertainty surrounding the proposed Merger; as well as more specific
risks and uncertainties discussed in our most recent report on Form 10 - K and subsequent reports on Forms 10 - Q and 8 - K available on the Investor Relations section of www.cigna.com as well as on Express Scripts» most recent report on Form 10 - K and subsequent reports on Forms 10 - Q and 8 - K available on the Investor Relations section of www.express-scripts.com.
Key information about the specific mortgages was lost in the process of securitizing mortgages in the first place, and then later repackaging these mortgage
securities into collateralized debt obligations (CDOs) and CDOs - squared.5 In addition, the complexity of the
securities meant that it would be difficult to understand the
risks even if an investor had access to all of the relevant mortgage -
level information.
The continued rising
levels of imports of foreign steel threaten to impair the national
security by placing the U.S. steel industry at substantial
risk of displacing the basic oxygen furnace and other steelmaking capacity, and the related supply chain needed to produce steel for critical infrastructure and national defense.
FedEx's executive
security procedures, which prescribe the
level of personal
security to be provided to the Chairman of the Board, President and Chief Executive Officer and other executive officers, are based on bona fide business - related
security concerns and are an integral part of FedEx's overall
risk management and
security program.
In fact, we consider that a portfolio of about 20
securities is the right balance between having a minimum diversification
level to reduce company - specific
risk while also having few enough companies to improve the odds of beating the market indices» Francois Rochon
The false sense of
security conveyed invites and encourages unwise and speculative
levels of leverage that in actuality conflate downside
risk when these schemes must be unwound.
Embedded in our investment process,
risk management is always on, with regular and rigorous reviews at the portfolio,
security and firm
levels.
Investment in these companies is speculative, volatile, and features a high
level of
risk,» Israel
Securities Authority (ISA) chairperson Anat Guetta said two weeks ago in announcing the ISA's decision to bar such companies from inclusion in Tel Aviv Stock Exchange indices.
In order to enhance the
level of «secure and controllability» for online products and services, prevent
security risks to...
Mr. Cummings is a recognized leader in advising organizations on the recruitment, assessment, development, and retention of information technology as well as information
security &
risk management talent at all
levels, including the Board of Directors.
Skilled active managers1 consider
risk throughout their investment process, continuously assessing and working to manage it at the
security, portfolio and firm
level.
Examples of these
risks, uncertainties and other factors include, but are not limited to the impact of: adverse general economic and related factors, such as fluctuating or increasing
levels of unemployment, underemployment and the volatility of fuel prices, declines in the
securities and real estate markets, and perceptions of these conditions that decrease the level of disposable income of consumers or consumer confidence; adverse events impacting the security of travel, such as terrorist acts, armed conflict and threats thereof, acts of piracy, and other international events; the risks and increased costs associated with operating internationally; our expansion into and investments in new markets; breaches in data security or other disturbances to our information technology and other networks; the spread of epidemics and viral outbreaks; adverse incidents involving cruise ships; changes in fuel prices and / or other cruise operating costs; any impairment of our tradenames or goodwill; our hedging strategies; our inability to obtain adequate insurance coverage; our substantial indebtedness, including the ability to raise additional capital to fund our operations, and to generate the necessary amount of cash to service our existing debt; restrictions in the agreements governing our indebtedness that limit our flexibility in operating our business; the significant portion of our assets pledged as collateral under our existing debt agreements and the ability of our creditors to accelerate the repayment of our indebtedness; volatility and disruptions in the global credit and financial markets, which may adversely affect our ability to borrow and could increase our counterparty credit risks, including those under our credit facilities, derivatives, contingent obligations, insurance contracts and new ship progress payment guarantees; fluctuations in foreign currency exchange rates; overcapacity in key markets or globally; our inability to recruit or retain qualified personnel or the loss of key personnel; future changes relating to how external distribution channels sell and market our cruises; our reliance on third parties to provide hotel management services to certain ships and certain other services; delays in our shipbuilding program and ship repairs, maintenance and refurbishments; future increases in the price of, or major changes or reduction in, commercial airline services; seasonal variations in passenger fare rates and occupancy levels at different times of the year; our ability to keep pace with developments in technology; amendments to our collective bargaining agreements for crew members and other employee relation issues; the continued availability of attractive port destinations; pending or threatened litigation, investigations and enforcement actions; changes involving the tax and environmental regulatory regimes in which we operate; and other factors set forth under «Risk Factors» in our most recently filed Annual Report on Form 10 - K and subsequent filings by the Company with the Securities and Exchange C
securities and real estate markets, and perceptions of these conditions that decrease the
level of disposable income of consumers or consumer confidence; adverse events impacting the
security of travel, such as terrorist acts, armed conflict and threats thereof, acts of piracy, and other international events; the
risks and increased costs associated with operating internationally; our expansion into and investments in new markets; breaches in data
security or other disturbances to our information technology and other networks; the spread of epidemics and viral outbreaks; adverse incidents involving cruise ships; changes in fuel prices and / or other cruise operating costs; any impairment of our tradenames or goodwill; our hedging strategies; our inability to obtain adequate insurance coverage; our substantial indebtedness, including the ability to raise additional capital to fund our operations, and to generate the necessary amount of cash to service our existing debt; restrictions in the agreements governing our indebtedness that limit our flexibility in operating our business; the significant portion of our assets pledged as collateral under our existing debt agreements and the ability of our creditors to accelerate the repayment of our indebtedness; volatility and disruptions in the global credit and financial markets, which may adversely affect our ability to borrow and could increase our counterparty credit
risks, including those under our credit facilities, derivatives, contingent obligations, insurance contracts and new ship progress payment guarantees; fluctuations in foreign currency exchange rates; overcapacity in key markets or globally; our inability to recruit or retain qualified personnel or the loss of key personnel; future changes relating to how external distribution channels sell and market our cruises; our reliance on third parties to provide hotel management services to certain ships and certain other services; delays in our shipbuilding program and ship repairs, maintenance and refurbishments; future increases in the price of, or major changes or reduction in, commercial airline services; seasonal variations in passenger fare rates and occupancy
levels at different times of the year; our ability to keep pace with developments in technology; amendments to our collective bargaining agreements for crew members and other employee relation issues; the continued availability of attractive port destinations; pending or threatened litigation, investigations and enforcement actions; changes involving the tax and environmental regulatory regimes in which we operate; and other factors set forth under «
Risk Factors» in our most recently filed Annual Report on Form 10 - K and subsequent filings by the Company with the
Securities and Exchange C
Securities and Exchange Commission.
Social
Security taxes and benefit
levels are not based on expected rates of return and
risk levels for various savings instruments (as is the case in private savings portfolios).
It also allows you to determine how to best diversify your
risk across a specific asset class, sector or industry while maintaining a specific
level of exposure to a specific
security.
Infant Mental Health Mentor — Research / Faculty (
Level IV) You will provide a research response to a Qualitative Question: You are encouraged to rely on your extensive research and teaching experience in the infant - family field related to the study of pregnancy, infancy, early childhood and early parenthood; attachment
security and relationship needs;
risk and resiliency in the early years; caregiving practices; early assessment and intervention strategies, and the mental health needs of infants and toddlers, to name a few.
Among the important factors that could cause Rio Tinto's actual results, performance or achievements to differ materially from those in the forward - looking statements include, among others,
levels of actual production during any period,
levels of demand and market prices, the ability to produce and transport products profitably, the impact of foreign currency exchange rates on market prices and operating costs, operational problems, political uncertainty and economic conditions in relevant areas of the world, the actions of competitors, activities by governmental authorities such as changes in taxation or regulation and such other
risk factors identified in Rio Tinto's most recent Annual Report on Form 20 - F filed with the United States
Securities and Exchange Commission (the «SEC») or Form 6 - Ks furnished to the SEC.
The models show that climate change is a less influential driver of global food
security than income, population and productivity — but it could still pose a significant
risk to the nutrition
levels of people living in the world's poorest regions, Baldos said.
«We need to come to terms with what an acceptable
level of
risk is when it comes to terrorism,» says William Banks of the Institute for National
Security and Counterterrorism at Syracuse University.
Devices can now communicate with each other via ultrasound, as the Internet of Things reaches the next
level — but experts warn of
security risks
These
risks and uncertainties include, among others, those relating to our ability to obtain financing and to form collaborative relationships, uncertainty regarding potential future deterioration in the market for auction rate
securities which could result in additional permanent impairment charges, our ability to develop and market diagnostic products, the level of third party reimbursement for our products, risks related to preclinical and clinical development of pharmaceutical products, including the identification of compounds and the completion of clinical trials, the effect of government regulation and the regulatory approval processes, market acceptance, our ability to obtain and protect intellectual property rights for our products, dependence on collaborative relationships, the effect of competitive products, industry trends and other risks identified in deCODE's filings with the Securities and Exchange Commission, including, without limitation, the risk factors identified in our most recent Annual Report on Form 10 - K and any updates to those risk factors filed from time to time in our Quarterly Reports on Form 10 - Q or Current Reports on F
securities which could result in additional permanent impairment charges, our ability to develop and market diagnostic products, the
level of third party reimbursement for our products,
risks related to preclinical and clinical development of pharmaceutical products, including the identification of compounds and the completion of clinical trials, the effect of government regulation and the regulatory approval processes, market acceptance, our ability to obtain and protect intellectual property rights for our products, dependence on collaborative relationships, the effect of competitive products, industry trends and other
risks identified in deCODE's filings with the
Securities and Exchange Commission, including, without limitation, the risk factors identified in our most recent Annual Report on Form 10 - K and any updates to those risk factors filed from time to time in our Quarterly Reports on Form 10 - Q or Current Reports on F
Securities and Exchange Commission, including, without limitation, the
risk factors identified in our most recent Annual Report on Form 10 - K and any updates to those
risk factors filed from time to time in our Quarterly Reports on Form 10 - Q or Current Reports on Form 8 - K.
In the context of IoNT, which WEF acknowledged to be the top emerging technology in 2016, the current work - in - progress, «ubiquitous» deployment of sensors in Malaysia and worldwide, I certainly see increasing data
security risks at the sensor, transmission, collection, processing and even analytics
levels.
These
risks and uncertainties include, among others, those relating to our ability to obtain sufficient financing to continue as a going concern, our ability to develop and market diagnostic products, the
level of third party reimbursement for our products,
risks related to preclinical and clinical development of pharmaceutical products, including the identification of compounds and the completion of clinical trials, our ability to form collaborative relationships, the effect of government regulation and the regulatory approval processes, market acceptance, our ability to obtain and protect intellectual property rights for our products, dependence on collaborative relationships, the effect of competitive products, industry trends and other
risks identified in deCODE's filings with the
Securities and Exchange Commission, including, without limitation, the
risk factors identified in our most recent Annual Report on Form 10 - K and any updates to those
risk factors filed from time to time in our Quarterly Reports on Form 10 - Q or Current Reports on Form 8 - K.
These
risks and uncertainties include, among others, those relating to our ability to obtain sufficient financing to continue as a going concern, the outcome of the review of the continued listing of our common stock on The Nasdaq Stock Market, our ability to develop and market diagnostic products, the
level of third party reimbursement for our products,
risks related to preclinical and clinical development of pharmaceutical products, including the identification of compounds and the completion of clinical trials, our ability to form collaborative relationships, the effect of government regulation and the regulatory approval processes, market acceptance, our ability to obtain and protect intellectual property rights for our products, dependence on collaborative relationships, the effect of competitive products, industry trends and other
risks identified in deCODE's filings with the
Securities and Exchange Commission, including, without limitation, the
risk factors identified in our most recent Annual Report on Form 10 - K and any updates to those
risk factors filed from time to time in our Quarterly Reports on Form 10 - Q or Current Reports on Form 8 - K.
Then discuss, secondarily,
risks and
security at a
level relevant to their age.»
The formal strategy will first assign an «owner» of
security who is likely to be a senior figure, and go on to define the «
security risk appetite» for the organisation: the
level of
risk that it is prepared to tolerate.
For higher
levels of
risk there are plenty of additional
security measures available, such as remote monitored CCTV, «SmokeCloak»,
security patrols, and permanent
security on site.
FAA has categorized the system
risk level (as specified in FIPS 199) and utilizes
security controls described in NIST SP800 - 53, Recommended Security Controls for Federal Information Systems, to accomplish privacy goals, where app
security controls described in NIST SP800 - 53, Recommended
Security Controls for Federal Information Systems, to accomplish privacy goals, where app
Security Controls for Federal Information Systems, to accomplish privacy goals, where applicable.
The results of these vulnerability scans will provide a
level of assurance that selected
security controls (identified during the RA) are operating as intended and are effective in minimizing operating
risk to ENS. Scan results will also provide FMCSA with the confidence that
security patches are effectively applied for all relevant software.
Important factors that could cause actual results to differ materially from those expressed or implied by such forward - looking statements include, without limitation, possible product defects and product liability,
risks related to international sales and potential foreign currency exchange fluctuations, the initiation or outcome of litigation, acts or potential acts of terrorism, international conflicts, significant fluctuations of quarterly operating results, changes in Canadian and foreign laws and regulations, continued acceptance of RIM's products, increased
levels of competition, technological changes and the successful development of new products, dependence on third - party networks to provide services, dependence on intellectual property rights, and other
risks and factors detailed from time to time in RIM's periodic reports filed with the United States
Securities and Exchange Commission, and other regulatory authorities.
The optimal portfolio aims to balance
securities with the greatest potential returns with an acceptable degree of
risk or
securities with the lowest degree of
risk for a given
level of potential return.
High - yield bonds (also known as «junk bonds») may be subject to greater
levels of interest rate, credit, and liquidity
risk than investments in higher rated
securities.
In addition, bond funds investing in longer - term
securities carry higher
levels of interest rate
risk.
Remember that these bouts of QE, LTRO operations, and other interventions have essentially had their effect by squeezing interest rates to
levels that are so low that investors feel forced to seek higher
risk securities in a search for yield.
Aladdin tools allow an in - depth look at a portfolio down to the
security level, and at the same time, give an overview of
risk factors such as sector and subsector exposures, yield curve, ratings, etc..
Investments in foreign
securities may involve
risks such as social and political instability, market illiquidity, exchange - rate fluctuations, a high
level of volatility and limited regulation.
Margin requirements are intended to help protect
securities firms and their customers from some of the
risks associated with leveraging investments by requiring customers to either meet or maintain certain
levels of equity in their account.
However, the fund does do a decent job of removing some of the worst
securities from the index and it may be a decent choice for those looking for greater exposure to small cap growth equities with lower
levels of
risk.
However, it is important to note that Alternative Investments carry a significantly higher
level of
risk compared to more traditional
securities.
An investment policy will specify what percentage of an investment portfolio must be in cash, list the investment goals, and identify acceptable
levels of
risk (defining, for example, maximum portfolio duration and the minimum credit rating for a
security in the portfolio).
To provide reasonable returns, commensurate with low
risk while providing a high
level of liquidity, through a portfolio of money market and debt
securities.
The FDIC - like
risk insurance program would provide support at the mortgage - backed
security, rather than at the entity,
level.
The investment objective of the Scheme is to provide reasonable returns and high
level of liquidity by investing in debt instruments such as bonds, debentures and Government
securities; and money market instruments such as treasury bills, commercial papers, certificates of deposit, including repos in permitted
securities of different maturities, so as to spread the
risk across different kinds of issuers in the debt markets.
The
security provided by the property results in a lower
level of
risk when compared to other unsecured loans.